TNF and COVID-19: This might explain why TNF antagonist treatment is not associated with adverse COVID-19 outcomes, as shown in some studies.4 It was suggested that anti-TNF monotherapy might have a protective effect against severe COVID-19 by blunting the cytokine storm related to severe disease.22 In fact, we found neither increased nor decreased risk of adverse outcomes with biologic use.